A drug used to treat breast cancer may also help bladder cancer patients, research suggests. Scientists found elevated levels of a protein called HER2 - targeted by the drug - in more than half of patients with advanced bladder cancer.
These patients were given herceptin and traditional chemotherapy - and in 70% of cases their tumors shrank. The drug is associated with fewer side effects than standard chemotherapy drugs.
The study, by the University of Michigan, was presented at an American Society of Clinical Oncology meeting.
